stockrow
Saturday 7 November 2026
Export EDVA’s income statement to Excel — free account
Splash Beverage Group, Inc.
EDVA Healthcare Biotechnology
Splash Beverage Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $73,100.00, down 98.2% from fiscal 2024.
- Revenue
- −99.6%
- EPS
- +95.6%
- Free cash flow
- −95.7%
- Total debt
- −100.0%
Quarter to June 2026, against a year earlier
0.19
0.02
+11.76%
Follow EDVA
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | 0.00 | 0.00 | — |
P/S ratio |
— | 0.92 | 2.48 | — | |
P/FCF ratio |
— | 0.00 | 0.00 | — | |
P/Operating CF |
— | (1.52) | (1.77) | — | |
P/B ratio |
— | 0.00 | 0.00 | — | |
Price to Tangible BV |
— | 0.00 | 0.00 | — | |
EV/Sales |
— | 0.87 | 2.21 | — | |
EV/EBITDA |
— | 0.00 | 0.00 | — | |
EV/Operating CF |
— | (0.30) | (0.30) | — | |
EV/FCF |
— | (0.30) | (0.30) | — | |
Quick Ratio |
0.04 | 0.02 | 0.03 | 0.02 | |
Current Ratio |
0.13 | 0.04 | 0.04 | 0.05 | |
Net Debt/EBITDA |
0.02 | 0.33 | 0.39 | 0.12 | |
Debt/Assets |
0.26% | 0.35% | 0.12% | 0.00% | |
Debt/Equity |
0.01 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.88 | 0.40 | 0.00 | |
Operating CF/Net income |
0.25 | 0.25 | 0.37 | 0.53 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 1.87 | |
Interest Coverage |
(29.83) | (1.57) | (1.10) | (8.69) | |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 29,660.00% | 23,204.76% | 0.00% | |
Intangible Assets out of Total Assets |
0.89 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 12,548.89% | 4,214.29% | 0.00% | |
Graham Net Nets |
— | (10.40) | (9.89) | — | |
Graham Number |
— | 177.15 | 118.03 | — | |
Earnings Yield |
— | (1,798.58%) | (3,030.62%) | — | |
Free Cash Flow Yield |
— | (320.98%) | (300.81%) | — | |
Revenue per Share |
0.00 | 0.01 | 0.00 | 0.00 | |
Operating CF per Share |
(4.51) | (1.82) | (0.81) | (0.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(4.51) | (1.82) | (0.81) | (0.35) | |
Cash per Share |
0.48 | 0.52 | 0.33 | 0.08 | |
Shareholders Equity per Share |
12.37 | (28.10) | (14.19) | (5.14) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.37 | (28.10) | (14.19) | (5.14) | |
Free Cash Flow |
(2.47) | (0.99) | (0.93) | (1.08) | |
Working Capital |
(13.67) | (15.63) | (16.26) | (15.92) | |
Capital Expenditures |
— | — | — | 0.01 | |
Net Current Asset Value |
(13.74) | (15.63) | (16.26) | (15.92) | |
EV/EBIT |
— | 0.00 | 0.00 | — | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
— | 0.00 | 0.00 | — | |
| Other line items | |||||
Average Receivables |
0.59 | 0.27 | 0.25 | 0.22 | |
Average Payables |
6.16 | 4.20 | 5.48 | 5.57 | |
Average Inventory |
1.10 | 0.18 | 0.46 | 0.46 | |
Average Assets |
15.43 | 1.86 | 1.64 | 11.66 | |
Average Common Equity |
(2.03) | (16.97) | (18.12) | (3.52) |
Columns are period end dates · fundamentals updated 26 Oct 2026